000			01995 a2200553 4500
005			20250514001756.0
264		0	_c20010816
008			200108s 0 0 eng d
022			_a0885-3185
024	7		_a10.1002/mds.1085 _2doi
040			_aNLM _beng _cNLM
100	1		_aHutton, J T
245	0	0	_aTransdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study. _h[electronic resource]
260			_bMovement disorders : official journal of the Movement Disorder Society _cMay 2001
300			_a459-63 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Cutaneous
650	0	4	_aAged
650	0	4	_aDopamine Agonists _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLevodopa _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aReceptors, Dopamine D2 _xagonists
650	0	4	_aTetrahydronaphthalenes _xadministration & dosage
650	0	4	_aTherapeutic Equivalency
650	0	4	_aThiophenes _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aMetman, L V
700	1		_aChase, T N
700	1		_aJuncos, J L
700	1		_aKoller, W C
700	1		_aPahwa, R
700	1		_aLeWitt, P A
700	1		_aSamii, A
700	1		_aTsui, J K
700	1		_aCalne, D B
700	1		_aWaters, C H
700	1		_aCalabrese, V P
700	1		_aBennett, J P
700	1		_aBarrett, R
700	1		_aMorris, J L
773	0		_tMovement disorders : official journal of the Movement Disorder Society _gvol. 16 _gno. 3 _gp. 459-63
856	4	0	_uhttps://doi.org/10.1002/mds.1085 _zAvailable from publisher's website
999			_c11322463 _d11322463